deflazacort

Generic: deflazacort

Labeler: amneal pharmaceuticals ny llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name deflazacort
Generic Name deflazacort
Labeler amneal pharmaceuticals ny llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

deflazacort 36 mg/1

Manufacturer
Amneal Pharmaceuticals NY LLC

Identifiers & Regulatory

Product NDC 60219-2285
Product ID 60219-2285_bf2296a0-7eb0-484f-b054-3d405c2c1dca
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217173
Listing Expiration 2026-12-31
Marketing Start 2025-12-12

Pharmacologic Class

Established (EPC)
corticosteroid [epc]
Mechanism of Action
corticosteroid hormone receptor agonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 602192285
Hyphenated Format 60219-2285

Supplemental Identifiers

RxCUI
153098 153880 1870954 1870958
UPC
0360219228313 0360219228511 0360219228412 0360219228214
UNII
KR5YZ6AE4B
NUI
N0000175576 N0000175450

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name deflazacort (source: ndc)
Generic Name deflazacort (source: ndc)
Application Number ANDA217173 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 36 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (60219-2285-1) / 30 TABLET in 1 BOTTLE
source: ndc

Packages (1)

Ingredients (1)

deflazacort (36 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "bf2296a0-7eb0-484f-b054-3d405c2c1dca", "openfda": {"nui": ["N0000175576", "N0000175450"], "upc": ["0360219228313", "0360219228511", "0360219228412", "0360219228214"], "unii": ["KR5YZ6AE4B"], "rxcui": ["153098", "153880", "1870954", "1870958"], "spl_set_id": ["18518568-a40b-41cb-91ce-44fbb5557971"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (60219-2285-1)  / 30 TABLET in 1 BOTTLE", "package_ndc": "60219-2285-1", "marketing_start_date": "20251212"}], "brand_name": "DEFLAZACORT", "product_id": "60219-2285_bf2296a0-7eb0-484f-b054-3d405c2c1dca", "dosage_form": "TABLET", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "60219-2285", "generic_name": "deflazacort", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DEFLAZACORT", "active_ingredients": [{"name": "DEFLAZACORT", "strength": "36 mg/1"}], "application_number": "ANDA217173", "marketing_category": "ANDA", "marketing_start_date": "20251212", "listing_expiration_date": "20261231"}